|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/27 | |||
| A61K 31/445 | |||
| A61K 31/55 |
| (11) | Number of the document | 2515886 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10790565.5 |
| Date of filing the European patent application | 2010-12-14 | |
| (97) | Date of publication of the European application | 2012-10-31 |
| (45) | Date of publication and mention of the grant of the patent | 2018-04-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/069654 |
| Date | 2010-12-14 |
| (87) | Number | WO 2011/076621 |
| Date | 2011-06-30 |
| (30) | Number | Date | Country code |
| 09180413 | 2009-12-22 | EP | |
| 10154648 | 2010-02-25 | EP |
| (72) |
PRINZ, Heike, DE
SCHURAD, Björn, DE
BECKERT, Thomas, DE
LINDER, Kristina, DE
|
| (73) |
Luye Pharma AG,
Am Windfeld 35, 83714 Miesbach,
DE
|
| (54) | TRANSDERMALES THERAPEUTISCHES SYSTEM ZUR VERABREICHUNG VON RIVASTIGMIN ODER DESSEN DERIVATEN |
| TRANSDERMAL THERAPEUTIC SYSTEM FOR ADMINISTERING RIVASTIGMINE OR DERIVATIVES THEREOF |